Skip to main content
SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
3.260
0.00 (0.00%)
Dec 23, 2024, 2:14 PM EST - Market open

SOPHiA GENETICS Revenue

SOPHiA GENETICS had revenue of $15.85M in the quarter ending September 30, 2024, a decrease of -2.76%. This brings the company's revenue in the last twelve months to $64.49M, up 9.85% year-over-year. In the year 2023, SOPHiA GENETICS had annual revenue of $62.37M with 31.14% growth.

Revenue (ttm)
$64.49M
Revenue Growth
+9.85%
P/S Ratio
3.32
Revenue / Employee
$149,972
Employees
430
Market Cap
216.59M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202362.37M14.81M31.14%
Dec 31, 202247.56M7.11M17.58%
Dec 31, 202140.45M12.05M42.43%
Dec 31, 202028.40M3.04M11.98%
Dec 31, 201925.36M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
LifeMD 193.06M
Zentalis Pharmaceuticals 40.56M
Profound Medical 8.98M
Inhibrx Biosciences 1.57M
Cardiff Oncology 688.00K
Inhibikase Therapeutics 1.00
Revenue Rankings

SOPH News

More News